S. J. Taj-aldeen, M. N. Gamaletsou, B. Rammaert, N. V. Sipsas, V. Zeller et al., Bone and joint infections caused by mucormycetes: a challenging osteoarticular mycosis of the twenty-first century, Med Mycol, vol.55, pp.691-704, 2017.

L. Lelievre, D. Garcia-hermoso, H. Abdoul, M. Hivelin, T. Chouaki et al., Posttraumatic mucormycosis: a nationwide study in France and review of the literature, Medicine, vol.93, pp.395-404, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01245722

D. Garcia-hermoso, A. Alanio, O. Lortholary, F. Dromer, J. Versalovic et al., Agents of systemic and subcutaneous mucormycosis and entomophthoromycosis, Section VI, Chapter 121, Manual of clinical microbiology, 2014.

E. Alvarez, D. Garcia-hermoso, D. A. Sutton, J. F. Cano, A. M. Stchigel et al., Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea, J Clin Microbiol, vol.48, pp.4410-4416, 2010.

P. W. Crous, M. J. Wingfield, T. I. Burgess, G. Hardy, P. A. Barber et al., Persoonia, vol.38, pp.240-384, 2017.

S. B. Saksena, A new genus of the Mucorales, Mycologia, vol.45, pp.426-436, 1953.

M. Z. Gomes, R. E. Lewis, and D. P. Kontoyiannis, Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species, Clin Microbiol Rev, vol.24, pp.411-445, 2011.

A. Skiada, L. Pagano, A. Groll, S. Zimmerli, B. Dupont et al., Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between, Clin Microbiol Infect, vol.17, pp.1859-1867, 2005.

J. A. Ribes, C. L. Vanover-sams, and D. J. Baker, Zygomycetes in human disease, Clin Microbiol Rev, vol.13, pp.236-301, 2000.

W. Vega, M. Orellana, L. Zaror, J. Gené, and J. Guarro, Saksenaea vasiformis infections: case report and literature review, Mycopathologia, vol.162, pp.289-294, 2006.

P. F. Pierce, M. B. Wood, G. D. Roberts, R. H. Fitzgerald, . Jr et al., Saksenaea vasiformis osteomyelitis, J Clin Microbiol, vol.25, p.933, 1987.

O. A. Cornely, S. Arikan-akdagli, E. Dannaoui, A. H. Groll, K. Lagrou et al., ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013, Clin Microbiol Infect, vol.20, pp.5-26, 2014.

Q. N. Sun, A. W. Fothergill, D. I. Mccarthy, M. G. Rinaldi, and J. R. Graybill, In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes, Antimicrob Agents Chemother, vol.46, pp.1581-1582, 2002.

V. Salas, F. J. Pastor, E. Calvo, D. Sutton, D. García-hermoso et al., Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole, Med Mycol, vol.50, pp.710-715, 2012.

F. Tissot, S. Agrawal, L. Pagano, G. Petrikkos, A. H. Groll et al., ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients, Haematologica, vol.102, pp.433-444, 2017.

J. Arockiaraj, G. Balaji, A. Ashok, and G. Kokil, Amphotericin B cement beads: a good adjunctive treatment for musculoskeletal mucormycosis, Indian J Orthop, vol.46, pp.369-372, 2012.

N. Vashi, R. Avedian, J. Brown, and S. Arai, Successful surgical and medical treatment of Rhizopus osteomyelitis following hematopoietic cell transplantation, Orthopedics, vol.35, pp.1556-61, 2012.

S. F. Heller, A. Pochettino, M. Rivera, and H. J. Schiller, Amphotericinimpregnated polymethylmethacrylate beads as treatment for soft tissue mucormycosis, Surgery, vol.162, pp.1330-1331, 2017.